Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Shares Outstanding (Weighted Average): 2015-2024

Historic Shares Outstanding (Weighted Average) for Astria Therapeutics (ATXS) over the last 10 years, with Dec 2024 value amounting to $56.4 million.

  • Astria Therapeutics' Shares Outstanding (Weighted Average) rose 66.07% to $2.0 million in Q4 2019 from the same period last year, while for Sep 2019 it was $1.9 million, marking a year-over-year increase of 63.53%. This contributed to the annual value of $56.4 million for FY2024, which is 55.48% up from last year.
  • Astria Therapeutics' Shares Outstanding (Weighted Average) amounted to $56.4 million in FY2024, which was up 55.48% from $36.3 million recorded in FY2023.
  • In the past 5 years, Astria Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $56.4 million in FY2024 and a low of $3.3 million during FY2020.
  • In the last 3 years, Astria Therapeutics' Shares Outstanding (Weighted Average) had a median value of $36.3 million in 2023 and averaged $36.5 million.
  • Data for Astria Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 288.64% (in 2021) over the last 5 years.
  • Astria Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $3.3 million in 2020, then soared by 288.64% to $13.0 million in 2021, then climbed by 29.33% to $16.8 million in 2022, then spiked by 115.72% to $36.3 million in 2023, then surged by 55.48% to $56.4 million in 2024.